Start Time: 08:00 January 1, 0000 8:44 AM ET
Esperion Therapeutics, Inc. (NASDAQ:ESPR)
Q2 2022 Earnings Conference Call
August 02, 2022, 08:00 AM ET
Company Participants
Sheldon Koenig - President and CEO
JoAnne Foody - CMO
Eric Warren - Chief Commercial Officer
BJ Swartz - Chief Strategy Officer
Tiffany Aldrich - Senior Manager, Corporate Communications
Conference Call Participants
Joseph Thome - Cowen
Michael Riad - Morgan Stanley
Michael Yee - Jefferies
Jessica Fye - JPMorgan
Judah Frommer - Credit Suisse
Serge Belanger - Needham & Company
Jason Butler - JMP Securities
Paul Choi - Goldman Sachs
Operator
Ladies and gentlemen, thank you for standing by and welcome. At this time, all participants are in a listen-only mode. Following the presentation, there will be a question-and-answer session. Be advised that today's conference call may be recorded.
I would now like to hand the conference over to Tiffany Aldrich, Senior Manager, Corporate Communications at Esperion. Please go ahead, Tiffany.
Tiffany Aldrich
Thank you, Carmen. Good morning and welcome to Esperion's Second Quarter 2022 Financial Results and Company Update Conference Call. I am Tiffany Aldrich, and I'm part of the Corporate Communications team here at Esperion.
I want to remind callers that the information discussed on the call today is covered under the Safe Harbor provisions of the Private Securities Litigation Reform Act. I caution listeners that management will be making forward-looking statements. Actual results could differ materially from those stated or implied by our forward-looking statements due to risks and uncertainties associated with the business. These forward-looking statements are qualified in their entirety by the cautionary statements contained in today's press release and our SEC filings.
The content of this conference call contains time-sensitive information that is accurate only as of the date of this live broadcast, August 2, 2022. We undertake no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date of this conference call and webcast. As a reminder, this conference call and webcast are being recorded and archived. We issued a press release this morning detailing the content of today's call. A copy can be found at www.esperion.com within the Investors and Media section. We will begin with prepared comments and then open the call for your questions. Following today's call, the team will be available for follow-up questions. Please e-mail corporateteam@esperion.com to schedule time to speak with the team.
With us today are Sheldon Koenig, President and CEO; Dr. JoAnne Foody, Chief Medical Officer; Eric Warren, Chief Commercial Officer; BJ Swartz, Chief Strategy Officer; and Ben Halladay from our Finance Department.